These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

342 related articles for article (PubMed ID: 32775374)

  • 41. Integrative omics analysis reveals relationships of genes with synthetic lethal interactions through a pan-cancer analysis.
    Guo L; Li S; Qian B; Wang Y; Duan R; Jiang W; Kang Y; Dou Y; Yang G; Shen L; Wang J; Liang T
    Comput Struct Biotechnol J; 2020; 18():3243-3254. PubMed ID: 33240468
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Expression and prognosis analysis of
    Li H; Li Q; Jing H; Zhao J; Zhang H; Ma X; Wei L; Dai R; Sun W; Suo Z
    Front Biosci (Landmark Ed); 2021 Oct; 26(10):707-716. PubMed ID: 34719199
    [No Abstract]   [Full Text] [Related]  

  • 43. PreMSIm: An R package for predicting microsatellite instability from the expression profiling of a gene panel in cancer.
    Li L; Feng Q; Wang X
    Comput Struct Biotechnol J; 2020; 18():668-675. PubMed ID: 32257050
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Linc00511 Indicates A Poor Prognosis Of Liver Hepatocellular Carcinoma.
    Hu P; Cui H; Lei T; Li S; Mai E; Jia F
    Onco Targets Ther; 2019; 12():9367-9376. PubMed ID: 31807017
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Prognostic and Immunotherapeutic Roles of KRAS in Pan-Cancer.
    Yang K; Li C; Liu Y; Gu X; Jiang L; Shi L
    Cells; 2022 Apr; 11(9):. PubMed ID: 35563733
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Correlation of MKI67 with prognosis, immune infiltration, and T cell exhaustion in hepatocellular carcinoma.
    Wu SY; Liao P; Yan LY; Zhao QY; Xie ZY; Dong J; Sun HT
    BMC Gastroenterol; 2021 Nov; 21(1):416. PubMed ID: 34724892
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Immunological function and prognostic value of lymphoid-specific helicase in liver hepatocellular carcinoma.
    Fang Y; Tang W; Zhao D; Zhang X; Li N; Yang Y; Jin L; Li Z; Wei B; Miao Y; Zeng Z; Huang H
    Cancer Biomark; 2023; 38(2):225-239. PubMed ID: 37545225
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effect of urokinase-type plasminogen activator combined with clinical stage and Barcelona Clinic Liver Cancer stage on the prognosis of patients with hepatocellular carcinoma.
    Wu J; Sun M; Li Z; Shen Y; Wu Y; Zhang H; Xu Z; Gao Q
    J Gastrointest Oncol; 2023 Jun; 14(3):1434-1450. PubMed ID: 37435232
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Prognostic impact of MICALL1 and associates with immune infiltration in liver hepatocellular carcinoma patients.
    Yang Y; Zhao W; Du J; Wang Y
    Cancer Biomark; 2023; 37(3):147-160. PubMed ID: 37248888
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Violations of proportional hazard assumption in Cox regression model of transcriptomic data in TCGA pan-cancer cohorts.
    Zeng Z; Gao Y; Li J; Zhang G; Sun S; Wu Q; Gong Y; Xie C
    Comput Struct Biotechnol J; 2022; 20():496-507. PubMed ID: 35070171
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The Prognostic and Immunotherapeutic Significance of AHSA1 in Pan-Cancer, and Its Relationship With the Proliferation and Metastasis of Hepatocellular Carcinoma.
    Li W; Liu J
    Front Immunol; 2022; 13():845585. PubMed ID: 35757728
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effect of let-7c on the PI3K/Akt/FoxO signaling pathway in hepatocellular carcinoma.
    Li Y; Li P; Wang N
    Oncol Lett; 2021 Feb; 21(2):96. PubMed ID: 33376529
    [TBL] [Abstract][Full Text] [Related]  

  • 53. KEAP1 overexpression is correlated with poor prognosis and immune infiltration in liver hepatocellular carcinoma.
    Wei X; Tang Y; Zheng M; Xu Y; Wang Z
    Front Med (Lausanne); 2024; 11():1391843. PubMed ID: 38938386
    [TBL] [Abstract][Full Text] [Related]  

  • 54. An Integrative Pan-Cancer Analysis of the Prognostic and Immunological Role of Casein Kinase 2 Alpha Protein 1 (CSNK2A1) in Human Cancers: A Study Based on Bioinformatics and Immunohistochemical Analysis.
    Wu R; Tang W; Qiu K; Li P; Li Y; Li D; He Z
    Int J Gen Med; 2021; 14():6215-6232. PubMed ID: 34621130
    [TBL] [Abstract][Full Text] [Related]  

  • 55. ASPM Is a Prognostic Biomarker and Correlates With Immune Infiltration in Kidney Renal Clear Cell Carcinoma and Liver Hepatocellular Carcinoma.
    Deng T; Liu Y; Zhuang J; Tang Y; Huo Q
    Front Oncol; 2022; 12():632042. PubMed ID: 35515103
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Role of CD5 molecular-like on hepatocellular carcinoma.
    Gao Z; Wu X; Yang L; Liu C; Wang X; Wang H; Dong K
    Chin Med J (Engl); 2023 Mar; 136(5):556-564. PubMed ID: 36939243
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Comprehensive analysis about prognostic and immunological role of WTAP in pan-cancer.
    Lei J; Fan Y; Yan C; Jiamaliding Y; Tang Y; Zhou J; Huang M; Ju G; Wu J; Peng C
    Front Genet; 2022; 13():1007696. PubMed ID: 36171885
    [No Abstract]   [Full Text] [Related]  

  • 58. Characterizing
    Jin X; Shi H; Li Z; Li H; Ma H; Shi X
    J Oncol; 2022; 2022():2717056. PubMed ID: 36213837
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Translocation of Methionine Adenosyl Transferase MAT2A and Its Prognostic Relevance for Liver Hepatocellular Carcinoma.
    Chu PY; Chou DA; Chen PM; Chiang EI
    Int J Mol Sci; 2023 May; 24(10):. PubMed ID: 37240447
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A pan-cancer analysis of the role of argininosuccinate synthase 1 in human tumors.
    Ding Q; Li R; Wang Q; Yu L; Zi F
    Front Oncol; 2023; 13():1049147. PubMed ID: 38053661
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.